A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance
Deyin Xing(Johns Hopkins Hospital), Sandra Oršulić(Cedars-Sinai Medical Center)
Cited by 99
Related Papers
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers
|Cancer Cell|2018|701
Sphingosine kinase 1 is required for TGF-β mediated fibroblast-to-myofibroblast differentiation in ovarian cancer
|Oncotarget|2015|59
INHBA(+) cancer-associated fibroblasts generate an immunosuppressive tumor microenvironment in ovarian cancer
|npj Precision Oncology|2024|39